Cargando…

Ocrelizumab/rituximab: SARS-CoV-2 infection: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379025/ http://dx.doi.org/10.1007/s40278-021-01158-z

Ejemplares similares

Ocrelizumab: SARS-CoV-2 pneumonia: 2 case reports
Publicado: (2020)

Ocrelizumab/rituximab: COVID-19 infection: 2 case reports
Publicado: (2021)

Rituximab: Reactivation of SARS-CoV-2 infection: case report
Publicado: (2021)

Rituximab: Reactivation of SARS-CoV-2 infection: case report
Publicado: (2021)

Leflunomide/rituximab: SARS-CoV-2 infection: case report
Publicado: (2021)

Ocrelizumab/rituximab: Various toxicities: 6 case reports
Publicado: (2021)

Rituximab: SARS-CoV-2 pneumonia: case report
Publicado: (2021)

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
por: Nytrova, Petra, et al.
Publicado: (2023)

Mycophenolate mofetil/prednisolone/rituximab: SARS-CoV-2 infection and lack of efficacy: 2 case reports
Publicado: (2022)

Prednisolone/rituximab: COVID-19 and SARS-CoV-2 pneumonia: case report
Publicado: (2021)

Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022)

Dexamethasone/prednisone/rituximab: Prolonged SARS-CoV-2 infection and off-label use: case report
Publicado: (2022)

Persistent SARS-CoV-2 Infection in a Multiple Sclerosis Patient on Ocrelizumab: A Case Report
por: Ambadapoodi, Raghava S., et al.
Publicado: (2023)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis
por: Gibson, Elena G, et al.
Publicado: (2021)

Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
por: Lucchini, Matteo, et al.
Publicado: (2020)

Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab
por: Van der Moeren, Nathalie, et al.
Publicado: (2022)

Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia
por: Conte, William L
Publicado: (2020)

Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
por: Shahbaz, Shima, et al.
Publicado: (2023)

Azathioprine: SARS-CoV-2 infection: case report
Publicado: (2021)

Temozolomide: SARS-CoV-2 infection: case report
Publicado: (2021)

Everolimus: SARS-CoV-2 infection: case report
Publicado: (2022)

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
por: Khayat-Khoei, Mahsa, et al.
Publicado: (2021)

Pneumocystis jirovecii pneumonia complicated a case of SARS‐CoV‐2 infection and multiple sclerosis after treatment with rituximab
por: Sadeghi Haddad Zavareh, Mahmoud, et al.
Publicado: (2023)

Ocrelizumab: Prolonged severe acute respiratory syndrome Coronavirus-2 infection: case report
Publicado: (2022)

Methotrexate/methylprednisolone/prednisone: Prolonged SARS-CoV-2 infection and masking of the symptoms of SARS-CoV-2 infection: case report
Publicado: (2020)

Co-infection with Legionella and SARS-CoV-2: a case report
por: Shimizu, Masaru, et al.
Publicado: (2021)

Adalimumab/vedolizumab: SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study
por: Conte, William L.
Publicado: (2021)

Rituximab: Failed to develop anti-SARS-Cov-2 antibodies: case report
Publicado: (2021)

Bendamustine/remdesivir/rituximab: Emergence of drug resistance and SARS-CoV-2 viraemia due to B-cell immunodeficiency : case report
Publicado: (2021)

Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report
por: Chaudhry, Rama, et al.
Publicado: (2021)

Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
por: Katz, J.D., et al.
Publicado: (2022)

Cyclophosphamide/doxorubicin: Prolongation of SARS-CoV-2 infection: case report
Publicado: (2021)

SARS-CoV-2 infection presenting as rhabdomyolysis: case report and review
por: Lamzouri, Oussama, et al.
Publicado: (2021)

Antithymocyte-globulin: Worsening of SARS-CoV-2 infection: case report
Publicado: (2020)

Brentuximab-vedotin/nivolumab: SARS-CoV-2 infection: case report
Publicado: (2020)

Case Report: Renal potassium wasting in SARS-CoV-2 infection
por: Mabillard, Holly, et al.
Publicado: (2020)

Thyrotoxicosis occurrence in SARS-CoV-2 infection: A case report
por: Pranasakti, Maria Erika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vmet8ic6vvsiusf5reqikp21q1